Neoadjuvant chemoimmunotherapy in HPV-associated vulvar and vaginal squamous cell carcinoma with PD-L1 CPS < 1:Dual pCR evidence
Neoadjuvant chemoimmunotherapy may be an effective treatment for HPV-associated vulvar/vaginal SCC, potentially independent of PD-L1 CPS status, while improving post-treatment quality of life compared to conventional therapies.
Authors
- Enyu Tang (ORCID: https://orcid.org/0000-0002-2058-0378)
- Jia Zeng (ORCID: https://orcid.org/0000-0002-9372-0685)
- Yangchun Sun
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1016/j.gore.2025.101952
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35